Skip to main content
main-content

Zeitschrift

Diabetes Therapy

Diabetes Therapy 2/2014

Ausgabe 2/2014

Inhaltsverzeichnis ( 20 Artikel )

01.12.2014 | Commentary | Ausgabe 2/2014 Open Access

Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?

William David Strain, Matthias Blüher, Païvi Paldánius

01.12.2014 | Review | Ausgabe 2/2014 Open Access

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology

Sanjay Kalra

01.12.2014 | Review | Ausgabe 2/2014 Open Access

The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist

Stephen C. Bain

01.12.2014 | Review | Ausgabe 2/2014 Open Access

A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes

George Dailey, Edward Wang

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus

Nozomi Domeki, Mihoko Matsumura, Tsuyoshi Monden, Yuki Nakatani, Yoshimasa Aso

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

Kohei Kaku, Hiroshi Maegawa, Yukio Tanizawa, Arihiro Kiyosue, Yumiko Ide, Takuto Tokudome, Yuji Hoshino, Jisin Yang, Anna Maria Langkilde

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

Jiten Vora, Torsten Christensen, Azhar Rana, Steve C. Bain

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes

Seamus Sreenan, Marc Andersen, Brian Larsen Thorsted, Michael L. Wolden, Marc Evans

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?

Bo Ahrén, James Edward Foley, Sylvie Dejager, Mouna Akacha, Qing Shao, Guenter Heimann, Markus Dworak, Anja Schweizer

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Patient Characteristics are not Associated with Clinically Important Differential Response to Dapagliflozin: a Staged Analysis of Phase 3 Data

Sarah Bujac, Angelo Del Parigi, Jennifer Sugg, Susan Grandy, Tom Liptrot, Martin Karpefors, Chris Chamberlain, Anne-Marie Boothman

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data

Zdravko Kamenov

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

Victoria Divino, Mitch DeKoven, Shawn Hallinan, Nebibe Varol, Sara Bruce Wirta, Won Chan Lee, Matthew Reaney

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes

Morgan Bron, Craig Wilson, Penny Fleck

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Role of Comorbidities as Limiting Factors to the Effect of Hyperbaric Oxygen in Diabetic Foot Patients: A Retrospective Analysis

Esra A. Akgül, Jale Karakaya, Salih Aydın

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Initial Experience and Evaluation of Reusable Insulin Pen Devices Among Patients with Diabetes in Emerging Countries

Balduino Tschiedel, Oscar Almeida, Jennifer Redfearn, Frank Flacke

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Improving Self-Monitoring of Blood Glucose among Adults with Type 1 Diabetes: Results of the Mobile™ Study

Jane Overland, Jessie Abousleiman, Andriana Chronopoulos, Natasha Leader, Lynda Molyneaux, Christopher Gilfillan

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK

Hayley Bennett, Phil McEwan, Klas Bergenheim, Jason Gordon

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States

Qian Li, Abhishek Chitnis, Mette Hammer, Jakob Langer

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden

Aliasghar A. Kiadaliri, Ulf G. Gerdtham, Bjorn Eliasson, Katarina Steen Carlsson

01.12.2014 | Erratum | Ausgabe 2/2014 Open Access

Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study

Borje Darpo, Meijian Zhou, Jessica Matthews, Hui Zhi, Malcolm A. Young, Caroline Perry, Rickey R. Reinhardt

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise